Matthieu Lilamand
- Geriatrics and Gerontology top 5%
- Frailty in Older Adults 10
- Physiology top 10%
- Alzheimer's disease research and treatments 12
- Nutrition and Health in Aging 8
- Diet and metabolism studies 4
- Psychiatry and Mental health top 10%
- Dementia and Cognitive Impairment Research 17
-
- Parkinson's Disease Mechanisms and Treatments 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Pain Management and Opioid Use 2
- Co-authors
- Claire PaquetMatteo CesariFrançois Mouton‐LigerEirini KelaiditiEmmanuel CognatA. Raynaud-SimonSophie GuyonnetJacques Hugon
- Journals
- PLoS ONE (1 paper)International Journal of Molecular Sciences (1 paper)European Heart Journal (1 paper)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Matthieu Lilamand
47 papers receiving 576 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Geriatrics and Gerontology 104
- Physiology 297
- Biological Psychiatry 26
- Psychiatry and Mental health 121
- Neurology 49
Countries citing papers authored by Matthieu Lilamand
This map shows the geographic impact of Matthieu Lilamand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Lilamand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Lilamand more than expected).
Fields of papers citing papers by Matthieu Lilamand
This network shows the impact of papers produced by Matthieu Lilamand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Lilamand. The network helps show where Matthieu Lilamand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthieu Lilamand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinicsbreakdown → | 2025 | 15 |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 14 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 3 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 18 | |
| 15 | 2015 | 19 | |
| 16 | 2015 | 20 | |
| 17 | 1990 | 5 | |
| 18 | 1989 | 38 | |
| 19 | [Efficacy criteria in the fulguration of the bundle of His]. | 1987 | 1 |
| 20 | Signification pronostique de l'hypertension artérielle pulmonaire dans les bronchopneumopathies chroniques obstructives. | 1981 | 1 |
About Matthieu Lilamand
Matthieu Lilamand is a scholar working on Geriatrics and Gerontology, Psychiatry and Mental health and Physiology, having authored 53 papers that have together received 590 indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (12 papers), Frailty in Older Adults (10 papers), Nutrition and Health in Aging (8 papers), Diet and metabolism studies (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Pain Management and Opioid Use (2 papers). The work is most often cited by research in Geriatrics and Gerontology (104 citations), Physiology (297 citations) and Biological Psychiatry (26 citations). Matthieu Lilamand has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Claire Paquet, Matteo Cesari, François Mouton‐Liger, Eirini Kelaiditi, Emmanuel Cognat, A. Raynaud-Simon, Sophie Guyonnet, Jacques Hugon, Bruno Vellas and Claire Hourrègue. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.